skip to content
Advertisement
Premium
This is an archive article published on December 20, 2017

Delhi: Max Hospital in Shalimar Bagh resumes operations, suspension of licence stayed

The hospital's licence on December 8 was then cancelled by DGHS under relevant sections of Delhi Nursing Home Registration Act.

Delhi: Max Hospital Shalimar Bagh resumes operations, suspension of licence stayed Max Hospital, Shalimar Bagh, resumes operations. (Amit Mehra/Express Archive)

After being shut down for ten days, Max Super Specialty in Shalimar Bagh  resumed its services on Wednesday. The hospital, whose licence was cancelled by the Directorate of Health Services, has received temporary relief from the court of financial commissioner, officials confirmed.

Max hospital, which had earlier erroneously declared a newborn as dead, was found to be prima facie guilty of gross medical negligence. Its licence on December 8 was then cancelled by DGHS under relevant sections of the Delhi Nursing Home Registration Act. The hospital had moved the court of financial commissioner, the appellate authority, challenging the DGHS order.

“On December 19, a stay order has been issued by the court of financial commissioner. The stay order is appicable till next date of hearing,” an official said. Sources said the court of financial commissioner is the appelate authority that looks into 22 statutory Acts passed by the Delhi government, including the Delhi Nursing Home Registration Act.

“Max Hospital Shalimar Bagh has resumed its operations from today, following a stay order issued by the appropriate Appellate authority to whom an appeal was made. We are fully focussed on providing quality care to all our patients and honouring our commitment of ensuring free treatment to the economically weaker sections of the society.” authorities at Max Hospital said.

Kaunain Sheriff M is an award-winning investigative journalist and the National Health Editor at The Indian Express. He is the author of Johnson & Johnson Files: The Indian Secrets of a Global Giant, an investigation into one of the world’s most powerful pharmaceutical companies. With over a decade of experience, Kaunain brings deep expertise in three areas of investigative journalism: law, health, and data. He currently leads The Indian Express newsroom’s in-depth coverage of health. His work has earned some of the most prestigious honours in journalism, including the Ramnath Goenka Award for Excellence in Journalism, the Society of Publishers in Asia (SOPA) Award, and the Mumbai Press Club’s Red Ink Award. Kaunain has also collaborated on major global investigations. He was part of the Implant Files project with the International Consortium of Investigative Journalists (ICIJ), which exposed malpractices in the medical device industry across the world. He also contributed to an international investigation that uncovered how a Chinese big-data firm was monitoring thousands of prominent Indian individuals and institutions in real time. Over the years, he has reported on several high-profile criminal trials, including the Hashimpura massacre, the 2G spectrum scam, and the coal block allocation case. Within The Indian Express, he has been honoured three times with the Indian Express Excellence Award for his investigations—on the anti-Sikh riots, the Vyapam exam scam, and the abuse of the National Security Act in Uttar Pradesh. ... Read More

Stay updated with the latest - Click here to follow us on Instagram

Latest Comment
Post Comment
Read Comments
Advertisement

You May Like

Advertisement